| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/17/2013 | CN103041130A Traditional Chinese medicine composition with effect of clearance resuscitation, and preparation method thereof |
| 04/17/2013 | CN103041095A Preparation method of Chinese yam capsules |
| 04/17/2013 | CN103040988A Chinese medicine composition for protecting waist and waist protecting belt |
| 04/17/2013 | CN103040906A Traditional Chinese medicine composition for treating spontaneous perspiration disease and preparation method thereof |
| 04/17/2013 | CN102302446B Recombinant human growth hormone injection capable of being directly used |
| 04/17/2013 | CN102260340B Chinese magnoliavine protein, and preparation method and medicinal application thereof |
| 04/17/2013 | CN102210782B Compound traditional Chinese medicine for treating glucocorticoid dependence and application thereof |
| 04/17/2013 | CN101626773B Agent for promoting healing of living body |
| 04/17/2013 | CN101433715B Modified chimeric polypeptides with improved pharmacokinetic properties |
| 04/17/2013 | CN101166732B Cyanopyridine derivative and use thereof as medicine |
| 04/16/2013 | US8420679 Aminothiazole derivatives and their use as CRF receptor ligands |
| 04/16/2013 | US8420630 Pyrimidine derivatives |
| 04/16/2013 | US8420396 For delivering DNA/RNA into cells |
| 04/16/2013 | US8420391 RNA sequence-specific mediators of RNA interference |
| 04/16/2013 | US8420350 Glycosylation-deficient hepatocyte growth factor |
| 04/16/2013 | US8420340 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 04/16/2013 | US8420077 Silk fibroin hydrogels and uses thereof |
| 04/16/2013 | CA2548273C Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 04/16/2013 | CA2478169C Human antibodies specific to kdr and uses thereof |
| 04/16/2013 | CA2271783C Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 04/11/2013 | WO2013051672A1 Medicinal agent comprising thiazolidine derivative or salt thereof as active ingredient |
| 04/11/2013 | WO2013051639A1 Pyrazoloquinoline derivative |
| 04/11/2013 | WO2013051632A1 Nitrogen-containing fused heterocyclic compound |
| 04/11/2013 | WO2013051531A1 Novel anti-hcv agent |
| 04/11/2013 | WO2013051459A1 Promoter capable of promoting inhibition of expression of mrna by rna interference, and use thereof |
| 04/11/2013 | WO2013051414A1 Pyrroloquinoline quinone alcohol adduct |
| 04/11/2013 | WO2013051330A1 Treatment of atrial fibrillation by means of vidarabine |
| 04/11/2013 | WO2013051266A1 Tau aggregation inhibitor |
| 04/11/2013 | WO2013051159A1 Nop receptor antagonist |
| 04/11/2013 | WO2013050404A1 Composition for the treatment of fistula |
| 04/11/2013 | WO2001027079A3 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/11/2013 | US20130089561 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 04/11/2013 | US20130089508 Compositions for enhancing nail health |
| 04/11/2013 | CA2851243A1 Compositions for enhancing nail health |
| 04/11/2013 | CA2850848A1 Composition for the treatment of fistula |
| 04/10/2013 | EP2578585A1 Purinone derivative |
| 04/10/2013 | EP2578574A1 Optically active dibenzylamine derivative, and manufacturing method for same |
| 04/10/2013 | EP2578569A1 Heterocyclic ring compound and h1 receptor antagonist |
| 04/10/2013 | EP2578233A1 Therapeutic agent for pancreatic cancer |
| 04/10/2013 | EP2578231A1 Antitumor t cell response enhancer |
| 04/10/2013 | EP2578224A1 Cell growth-promoting peptide and use thereof |
| 04/10/2013 | EP2578216A1 Methods of treating fragile x syndrome |
| 04/10/2013 | EP2578211A1 6-decaprenyl-2,3-dimethoxy-5-methyl-1,4-benzoquinone-based composition and method for the production thereof |
| 04/10/2013 | EP2575896A2 Magnetically responsive membrane structures |
| 04/10/2013 | CN103038218A Condensed ring pyridine compound |
| 04/10/2013 | CN103037854A Novel use of panduratin derivatives or an extract of boesenbergia pandurata for promoting muscle mass growth, fighting fatigue, and enhancing exercise performance capability |
| 04/10/2013 | CN103030654A Micromolecular c-Met protein kinase inhibitor |
| 04/10/2013 | CN103028117A Method for preparing bacterial cellulose gel composite material |
| 04/10/2013 | CN103028096A Traditional Chinese medicine recipe for treating sweating syndromes |
| 04/10/2013 | CN103027987A Preparation technology and production method of integrative new dosage form of Radix Platycodonis and Fructus Aurantii decoction |
| 04/10/2013 | CN103027973A Preparation technology and production method of integrative new dosage form of Rhizoma Atractylodis Macrocephalae and Radix aconiti lateralis preparata decoction |
| 04/10/2013 | CN103027940A Traditional Chinese medicine composition for treating night sweat of adult |
| 04/10/2013 | CN101959518B Pharmaceutical composition and poria extract useful for enhancing absorption of nutrients |
| 04/10/2013 | CN101874807B Application of lanosterol and tuckahoe extract in treating cachexia |
| 04/10/2013 | CN101712679B Acylamide class compound, medicine composition, preparation method and application thereof |
| 04/10/2013 | CN101664552B Stabilization of hypoxia inducible factor (HIF) alpha |
| 04/10/2013 | CN101605784B Aza-bridged-ring compound |
| 04/10/2013 | CN101454334B Macrolide derivatives |
| 04/10/2013 | CN101138576B Codonopsis pilosula fermentation liquor and uses thereof |
| 04/09/2013 | US8415480 Thiazolidine carboxamide derivatives as modulators of the prostaglandin F receptor |
| 04/09/2013 | US8415327 Methods of and compositions for reducing cell death |
| 04/09/2013 | US8415318 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 04/09/2013 | US8415300 Sustained release of microcrystalline peptide suspensions |
| 04/09/2013 | US8414916 Chewable soft capsule |
| 04/09/2013 | CA2749172C Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 04/09/2013 | CA2737565C N-phenyl-2-pyrimidine-amine derivatives |
| 04/09/2013 | CA2450777C Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
| 04/09/2013 | CA2446929C Orally administering parathyroid hormone and calcitonin |
| 04/04/2013 | WO2013048345A1 Methods and pharmaceutical compositions for treating cancer |
| 04/04/2013 | WO2013047869A1 Pharmaceutical composition containing loxoprofen or salt thereof |
| 04/04/2013 | WO2013047846A1 Glycosylated polypeptide and pharmaceutical composition containing same |
| 04/04/2013 | WO2013047813A1 1,2,4-triazine-6-carboxamide derivative |
| 04/04/2013 | WO2013047729A1 Antigen-binding molecule inducing immune response to target antigen |
| 04/04/2013 | WO2013047725A1 Drug for the treatment of allergic rhinitis comprising pgd2 antagonist and histamine antagonist |
| 04/04/2013 | WO2013047701A1 Phenyl derivative |
| 04/04/2013 | WO2013047665A1 Preservative for low-temperature preservation of biological materials, and method for preserving biological materials at low temperatures |
| 04/04/2013 | WO2013047568A1 Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide |
| 04/04/2013 | WO2013047567A1 Corneal epithelial cell death inhibitor containing flavin adenine dinucleotide or salt thereof as active ingredient |
| 04/04/2013 | WO2013047509A1 Novel phosphatidylinositol-3-kinase inhibitor and pharmaceutical composition |
| 04/04/2013 | WO2013047128A1 Peptide and angiotensin-converting enzyme inhibitor |
| 04/04/2013 | WO2013046813A1 Enhancer of expression of biological defense function factor |
| 04/04/2013 | WO2013045963A1 A pharmaceutical composition for the treatment of stem cells |
| 04/04/2013 | WO2013045380A2 Pharmaceutically acceptable mglur5 positive allosteric modulators and their methods of identification |
| 04/04/2013 | US20130086701 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 04/04/2013 | US20130085174 Acne treatment |
| 04/04/2013 | US20130085156 Novel 2-pyridinecarboxamide derivatives |
| 04/04/2013 | US20130085096 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 04/04/2013 | US20130084310 Compositions and methods for platelet enriched fibrin constructs |
| 04/04/2013 | US20130084300 Diagnosis and prevention of cancer cell invasion |
| 04/04/2013 | US20130084290 Antibodies to Thymic Stromal Lymphopoietin (TSLP) Receptor Molecules and Uses Thereof |
| 04/04/2013 | CA2850469A1 Glycosylated polypeptide and pharmaceutical composition containing same |
| 04/04/2013 | CA2850322A1 Antigen-binding molecule inducing immune response to target antigen |
| 04/04/2013 | CA2850190A1 Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide |
| 04/04/2013 | CA2849000A1 Phenyl derivative |
| 04/03/2013 | EP2574336A1 Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism |
| 04/03/2013 | CN1622958B Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto |
| 04/03/2013 | CN1555268B Therapeutic agents comprising pro-apoptotic proteins |
| 04/03/2013 | CN1526018B Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 04/03/2013 | CN103025750A VEGF production promoter |
| 04/03/2013 | CN103025725A Hetero ring compound |